skip to main content
Idioma:
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Journals@Ovid Full Text remover Base de dados/Biblioteca: ScienceDirect Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
09:20 AM: Optimal Treatment of Acute Acoustic Trauma in the Chinchilla
09:20 AM: Optimal Treatment of Acute Acoustic Trauma in the Chinchilla
Material Type:
Artigo 		Adicionar ao Meu Espaço

09:20 AM: Optimal Treatment of Acute Acoustic Trauma in the Chinchilla

Patterson, Matthew B ; Coleman, John KM ; Balough, Ben J ; Hoffer, Michael E ; Harper, Elizabeth ; Jackson, Ronald

Otolaryngology-head and neck surgery, 2006-08, Vol.135 (2_suppl), p.P79-P80 [Periódico revisado por pares]

Los Angeles, CA: SAGE Publications

Texto completo disponível

Citações Citado por
2
09:50: Prevention of Synaptic Edema by Noise Exposure in Chinchilla
09:50: Prevention of Synaptic Edema by Noise Exposure in Chinchilla
Material Type:
Artigo 		Adicionar ao Meu Espaço

09:50: Prevention of Synaptic Edema by Noise Exposure in Chinchilla

Ge, Xianxi ; Jackson, Ronald L. ; Coleman, John K.M. ; Kopke, Richard D. ; Balough, Ben J.

Otolaryngology-head and neck surgery, 2007-08, Vol.137 (2), p.P135-P136 [Periódico revisado por pares]

Los Angeles, CA: Mosby, Inc

Texto completo disponível

Citações Citado por
3
1001P - Effect of response to last platinum-based chemotherapy in patients (pts) with platinum-sensitive, recurrent ovarian carcinoma in the phase III study ARIEL3 of rucaparib maintenance treatment
1001P - Effect of response to last platinum-based chemotherapy in patients (pts) with platinum-sensitive, recurrent ovarian carcinoma in the phase III study ARIEL3 of rucaparib maintenance treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

1001P - Effect of response to last platinum-based chemotherapy in patients (pts) with platinum-sensitive, recurrent ovarian carcinoma in the phase III study ARIEL3 of rucaparib maintenance treatment

Ledermann, J.A. ; Oza, A.M. ; Lorusso, D. ; Aghajanian, C. ; Oaknin, A. ; Dean, A. ; Colombo, N. ; Weberpals, J.I. ; Clamp, A.R. ; Scambia, G. ; Leary, A. ; Holloway, R.W. ; Gancedo, M Amenedo ; Fong, P.C. ; Goh, J.C. ; O’Malley, D.M. ; Cameron, T. ; Maloney, L. ; Goble, S. ; Coleman, R.L.

Annals of oncology, 2019-10, Vol.30, p.v408-v409 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
4
1001PEffect of response to last platinum-based chemotherapy in patients (pts) with platinum-sensitive, recurrent ovarian carcinoma in the phase III study ARIEL3 of rucaparib maintenance treatment
1001PEffect of response to last platinum-based chemotherapy in patients (pts) with platinum-sensitive, recurrent ovarian carcinoma in the phase III study ARIEL3 of rucaparib maintenance treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

1001PEffect of response to last platinum-based chemotherapy in patients (pts) with platinum-sensitive, recurrent ovarian carcinoma in the phase III study ARIEL3 of rucaparib maintenance treatment

Ledermann, J A ; Oza, A M ; Lorusso, D ; Aghajanian, C ; Oaknin, A ; Dean, A ; Colombo, N ; Weberpals, J I ; Clamp, A R ; Scambia, G ; Leary, A ; Holloway, R W ; Gancedo, M Amenedo ; Fong, P C ; Goh, J C ; O’Malley, D M ; Cameron, T ; Maloney, L ; Goble, S ; Coleman, R L

Annals of oncology, 2019-10, Vol.30 (Supplement_5) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
5
1002PIntegrated safety analysis of the poly (ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with ovarian cancer in the treatment and maintenance settings
1002PIntegrated safety analysis of the poly (ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with ovarian cancer in the treatment and maintenance settings
Material Type:
Artigo 		Adicionar ao Meu Espaço

1002PIntegrated safety analysis of the poly (ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with ovarian cancer in the treatment and maintenance settings

Kristeleit, R S ; Oza, A M ; Oaknin, A ; Aghajanian, C ; Tinker, A V ; Tredan, O ; O’Malley, D M ; Leary, A ; Konecny, G E ; Lorusso, D ; Weberpals, J I ; Goble, S ; Maloney, L ; Cameron, T ; Swisher, E ; McNeish, I A ; Shapira-Frommer, R ; Ledermann, J A ; Coleman, R L

Annals of oncology, 2019-10, Vol.30 (Supplement_5) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
6
101 Environmental conditions in equine indoor arenas: A descriptive study
101 Environmental conditions in equine indoor arenas: A descriptive study
Material Type:
Artigo 		Adicionar ao Meu Espaço

101 Environmental conditions in equine indoor arenas: A descriptive study

McGill, S. ; Hayes, M. ; Coleman, R.

Journal of equine veterinary science, 2023-05, Vol.124 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
7
1030P - Impact of prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer (ROC): Sub-group analysis from a randomized, open-label study comparing trabectedin (T) and PLD versus PLD alone in ROC (ET743-OVC-3006)
1030P - Impact of prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer (ROC): Sub-group analysis from a randomized, open-label study comparing trabectedin (T) and PLD versus PLD alone in ROC (ET743-OVC-3006)
Material Type:
Artigo 		Adicionar ao Meu Espaço

1030P - Impact of prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer (ROC): Sub-group analysis from a randomized, open-label study comparing trabectedin (T) and PLD versus PLD alone in ROC (ET743-OVC-3006)

Monk, B.J. ; Herzog, T.J. ; Triantos, S. ; Maul, S. ; Wang, G. ; Valero, M J Pontes ; McGowan, T. ; Shalaby, W.S. ; Coleman, R.L.

Annals of oncology, 2019-10, Vol.30, p.v420-v421 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
8
1030PImpact of prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer (ROC): Sub-group analysis from a randomized, open-label study comparing trabectedin (T) and PLD versus PLD alone in ROC (ET743-OVC-3006)
1030PImpact of prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer (ROC): Sub-group analysis from a randomized, open-label study comparing trabectedin (T) and PLD versus PLD alone in ROC (ET743-OVC-3006)
Material Type:
Artigo 		Adicionar ao Meu Espaço

1030PImpact of prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer (ROC): Sub-group analysis from a randomized, open-label study comparing trabectedin (T) and PLD versus PLD alone in ROC (ET743-OVC-3006)

Monk, B J ; Herzog, T J ; Triantos, S ; Maul, S ; Wang, G ; Valero, M J Pontes ; McGowan, T ; Shalaby, W S ; Coleman, R L

Annals of oncology, 2019-10, Vol.30 (Supplement_5) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
9
1059TiP - Tumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study
1059TiP - Tumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

1059TiP - Tumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study

Vergote, I.B. ; Copeland, L. ; Monk, B.J. ; Coleman, R.L. ; Cibula, D. ; Sehouli, J. ; Samartzis, E.P. ; Radoslaw, M. ; Martín, A González ; Korach, J. ; Salutari, V. ; Witteveen, P.O. ; O’Malley, D.

Annals of oncology, 2019-10, Vol.30, p.v431-v431 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
10
1059TiPTumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study
1059TiPTumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

1059TiPTumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study

Vergote, I B ; Copeland, L ; Monk, B J ; Coleman, R L ; Cibula, D ; Sehouli, J ; Samartzis, E P ; Radoslaw, M ; Martín, A González ; Korach, J ; Salutari, V ; Witteveen, P O ; O’Malley, D

Annals of oncology, 2019-10, Vol.30 (Supplement_5) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (1.199)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (1.196)
  2. Anais de Congresso  (12)
  3. Outros  (5)
  4. Reports  (2)
  5. Web Resources  (1)
  6. Recursos Textuais  (1)
  7. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1970  (20)
  2. 1970Até1983  (58)
  3. 1984Até1996  (161)
  4. 1997Até2010  (383)
  5. Após 2010  (595)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (1.215)
  2. Japonês  (124)
  3. Alemão  (1)
  4. Norueguês  (1)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.